Docoh
Loading...

HALO Halozyme Therapeutics

News

From Benzinga Pro
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
10 Aug 21
Biotech, Earnings, News, Penny Stocks, Guidance, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9)
Halozyme Stock Gains As Q2 Earnings Top Estimates On Higher Milestone, Royalty; Lifts FY21 Guidance
10 Aug 21
Biotech, Earnings, Long Ideas, News, Guidance, Health Care, Movers, Trading Ideas, General
Halozyme Therapeutics: Q2 Earnings Insights
9 Aug 21
Earnings
Shares of Halozyme Therapeutics (NASDAQ:HALO) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 247.37% over the past year to $0.66, which beat the estimate of $0.40.
Halozyme Therapeutics Q2 Adj. EPS $0.66 Beats $0.40 Estimate, Sales $136.50M Beat $103.16M Estimate; Raises Guidance
9 Aug 21
Earnings, News, Guidance
Halozyme Therapeutics (NASDAQ:HALO) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.40 by 65 percent. This is a 247.37 percent increase over earnings of $0.19 per share from
Earnings Scheduled For August 9, 2021
9 Aug 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
8 Aug 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, IPOs, Top Stories, General
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

Press releases

From Benzinga Pro
Halozyme To Host Third Quarter 2021 Financial Results Webcast and Conference Call
19 Oct 21
Press Releases
SAN DIEGO, Oct. 19, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) will webcast its Quarterly Update Conference Call for the third quarter 2021 on November 2 at 4:30 p.m. ET / 1:30 p.m. PT. Dr. Helen
Halozyme to Participate in the 2021 Cantor Virtual Global Healthcare Conference
15 Sep 21
Press Releases
SAN DIEGO, Sept. 15, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) today announced that Elaine Sun, senior vice president and chief financial officer, will present at the 2021 Cantor Virtual Global
Halozyme to Present at Wells Fargo 2021 Virtual Healthcare Conference
26 Aug 21
Press Releases
SAN DIEGO, Aug. 26, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) today announced that Dr. Helen Torley, president and chief executive officer, will present at the Wells Fargo 2021 Virtual Healthcare
Thinking about trading options or stock in Halozyme Therapeutics, GameStop, Digital Turbine, Tesla, or Moderna?
10 Aug 21
Opinion, Press Releases
NEW YORK, Aug. 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HALO, GME, APPS, TSLA, and MRNA.
Halozyme Reports Second Quarter 2021 Results
9 Aug 21
Earnings, Press Releases
SAN DIEGO, Aug. 9, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) today reported financial results for the second quarter ended June 30, 2021 and provided an update on its recent corporate activities and
Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference
30 Jul 21
Press Releases
SAN DIEGO, July 30, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) today announced that Elaine Sun, senior vice president and chief financial officer, will virtually represent the company in a fireside
Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call
27 Jul 21
Press Releases
SAN DIEGO, July 27, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) will webcast its Quarterly Update Conference Call for the second quarter 2021 on Monday, August 9 at 4:30 p.m. ET / 1:30 p.m. PT. Dr.